ID23441A - Komposisi yang mengandung fructan untuk pencegahan dan pengobatan kanker usus dan metode untuk pencegahan dan pengobatan kanker usus - Google Patents

Komposisi yang mengandung fructan untuk pencegahan dan pengobatan kanker usus dan metode untuk pencegahan dan pengobatan kanker usus

Info

Publication number: ID23441A
Authority: ID; Indonesia
Prior art keywords: prevention; treatment; cancer; composition; fructan
Prior art date: 1997-05-20

Application number

IDW991303A

Other languages

English (en)

Indonesian (id)

Inventor

Van Loo

Frippiat

Original Assignee

Tiense Suikerraffinaderij Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-20

Filing date

1998-05-14

Publication date

2000-04-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8231000&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID23441(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-05-14 Application filed by Tiense Suikerraffinaderij Nv filed Critical Tiense Suikerraffinaderij Nv

2000-04-20 Publication of ID23441A publication Critical patent/ID23441A/id

Links

230000002265 prevention Effects 0.000 title abstract 4
229920002670 Fructan Polymers 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 2
206010028980 Neoplasm Diseases 0.000 title 2
201000011510 cancer Diseases 0.000 title 2
241000283690 Bos taurus Species 0.000 abstract 2
206010009944 Colon cancer Diseases 0.000 abstract 2
241000282414 Homo sapiens Species 0.000 abstract 2
229920001202 Inulin Polymers 0.000 abstract 2
208000029742 colonic neoplasm Diseases 0.000 abstract 2
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 2
229940029339 inulin Drugs 0.000 abstract 2
241000124008 Mammalia Species 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
235000013376 functional food Nutrition 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/055—Organic compounds containing sulfur as heteroatom
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Polymers & Plastics (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nutrition Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

IDW991303A 1997-05-20 1998-05-14 Komposisi yang mengandung fructan untuk pencegahan dan pengobatan kanker usus dan metode untuk pencegahan dan pengobatan kanker usus ID23441A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP97870069A EP0879600A1 (en)	1997-05-20	1997-05-20	Fructan containing composition for the prevention and treatment of colon cancer

Publications (1)

Publication Number	Publication Date
ID23441A true ID23441A (id)	2000-04-20

Family

ID=8231000

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW991303A ID23441A (id)	1997-05-20	1998-05-14	Komposisi yang mengandung fructan untuk pencegahan dan pengobatan kanker usus dan metode untuk pencegahan dan pengobatan kanker usus

Country Status (13)

Country	Link
US (1)	US6500805B2 (da)
EP (2)	EP0879600A1 (da)
JP (2)	JP2001526671A (da)
KR (1)	KR100529271B1 (da)
CN (1)	CN1177593C (da)
AT (1)	ATE274349T1 (da)
AU (1)	AU7654898A (da)
CA (1)	CA2290482C (da)
DE (1)	DE69825887T3 (da)
DK (1)	DK0983072T4 (da)
ES (1)	ES2223130T5 (da)
ID (1)	ID23441A (da)
WO (1)	WO1998052578A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5952033A (en) *	1996-12-24	1999-09-14	Nestec S.A.	Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
NL1012300C2 (nl) *	1999-06-11	2000-12-12	Rijksuniversiteit	Stabilisator voor farmaca.
DE10006086A1 (de) *	2000-02-11	2001-08-23	Albert Kloeti	Hundegetränk
EP1125507A1 (en)	2000-02-15	2001-08-22	Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)	Inulin products with improved nutritional properties
US7431939B1 (en) *	2000-09-28	2008-10-07	Mississippi State University	Inhibition of systemic infections in humans and vertebrates by dietary fibers
JP4307259B2 (ja)	2001-09-26	2009-08-05	フジ日本精糖株式会社	イヌリンの製造方法
US20040001898A1 (en) *	2002-06-26	2004-01-01	Armand Malnoe	Compositions and methods for detoxification and cancer prevention
EP1428528A1 (en) *	2002-09-27	2004-06-16	Tiense Suikerraffinaderij N.V.	Synergistic combinations of dietary fiber and NSAIDs for the treatment of cancer
FR2848783B1 (fr) *	2002-12-18	2005-05-13	Agronomique Inst Nat Rech	Utilisation de prebiotiques pour prevenir ou traiter le stress oxydant
US20050118234A1 (en) *	2003-12-01	2005-06-02	The Iams Company	Methods and kits related to administration of a fructooligosaccharide
US20050119222A1 (en)	2003-12-01	2005-06-02	The Iams Company	Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
JO3112B1 (ar)	2010-03-29	2017-09-20	Ferring Bv	تركيبة دوائية سريعة التحلل
MX341200B (es) *	2010-03-29	2016-08-11	Ferring Bv	Composicion farmaceutica de disolucion rapida.
CN105168515B (zh) *	2015-10-19	2017-03-15	智优生物科技（上海）有限公司	一种利于早期癌症自愈的组合物
CN107050046A (zh) *	2017-01-24	2017-08-18	北京神州航天食品技术研究院	一种抗肿瘤药物
GB2581531A (en) *	2019-02-25	2020-08-26	Akromaa Afolabi Bene	Deoxycholic - bound inulin
EP4034253B1 (en) *	2019-09-23	2026-01-21	The Regents Of The University Of Michigan	Compositions for increasing the efficacy of immunotherapies and vaccines
JP2022035343A (ja) *	2020-08-20	2022-03-04	株式会社ドアーズ	がん細胞のアポトーシス促進、及び／又は、増殖抑制剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6089427A (ja) *	1983-10-21	1985-05-20	Dainippon Pharmaceut Co Ltd	抗腫瘍剤
JPS61231966A (ja) *	1985-04-06	1986-10-16	Nikken Food Honsha Kk	腸内有用細菌の増殖用食品
JPS6393729A (ja) *	1986-10-09	1988-04-25	Sekisui Chem Co Ltd	悪性腫瘍等の治療方法
US5422346A (en) *	1988-01-06	1995-06-06	California Natural Products	Instant dried dahlia inulin juice and its method of production and usage
JPH02172921A (ja) *	1988-12-26	1990-07-04	Nitto Denko Corp	抗腫瘍剤の製造法
JP2982372B2 (ja) *	1990-03-16	1999-11-22	味の素株式会社	ポリフラクタンを含有する飲料
JP2827492B2 (ja) *	1990-10-04	1998-11-25	味の素株式会社	改質フラクトースポリマーの製造法
EP0692252B1 (en) *	1994-06-14	2001-04-04	"Raffinerie Tirlemontoise", société anonyme:	Use of a composition containing inulin or oligofructose in cancer treatment
US5563173A (en) *	1994-12-22	1996-10-08	Research Development Foundation	Anti-proliferative effects of sodium butyrate
GB9625129D0 (en) *	1996-12-03	1997-01-22	Cerestar Holding Bv	Highly fermentable resistant starch

1997
- 1997-05-20 EP EP97870069A patent/EP0879600A1/en not_active Withdrawn
1998
- 1998-05-14 ID IDW991303A patent/ID23441A/id unknown
- 1998-05-14 KR KR10-1999-7010687A patent/KR100529271B1/ko not_active Expired - Fee Related
- 1998-05-14 DE DE69825887T patent/DE69825887T3/de not_active Expired - Lifetime
- 1998-05-14 CN CNB988051273A patent/CN1177593C/zh not_active Expired - Fee Related
- 1998-05-14 EP EP98924315A patent/EP0983072B2/en not_active Expired - Lifetime
- 1998-05-14 CA CA002290482A patent/CA2290482C/en not_active Expired - Fee Related
- 1998-05-14 WO PCT/EP1998/002864 patent/WO1998052578A1/en not_active Ceased
- 1998-05-14 US US09/424,168 patent/US6500805B2/en not_active Expired - Fee Related
- 1998-05-14 AU AU76548/98A patent/AU7654898A/en not_active Abandoned
- 1998-05-14 JP JP54992298A patent/JP2001526671A/ja active Pending
- 1998-05-14 ES ES98924315T patent/ES2223130T5/es not_active Expired - Lifetime
- 1998-05-14 DK DK98924315T patent/DK0983072T4/da active
- 1998-05-14 AT AT98924315T patent/ATE274349T1/de not_active IP Right Cessation
2009
- 2009-02-04 JP JP2009023494A patent/JP2009275028A/ja active Pending

Also Published As

Publication number	Publication date
WO1998052578A1 (en)	1998-11-26
CN1255855A (zh)	2000-06-07
CA2290482C (en)	2005-03-08
EP0983072A1 (en)	2000-03-08
KR100529271B1 (ko)	2005-11-17
DE69825887T3 (de)	2009-10-08
DK0983072T4 (da)	2008-09-22
AU7654898A (en)	1998-12-11
US20020177561A1 (en)	2002-11-28
EP0983072B1 (en)	2004-08-25
KR20010012726A (ko)	2001-02-26
ATE274349T1 (de)	2004-09-15
US6500805B2 (en)	2002-12-31
DE69825887D1 (de)	2004-09-30
CA2290482A1 (en)	1998-11-26
EP0983072B2 (en)	2008-07-16
JP2001526671A (ja)	2001-12-18
CN1177593C (zh)	2004-12-01
ES2223130T3 (es)	2005-02-16
EP0879600A1 (en)	1998-11-25
JP2009275028A (ja)	2009-11-26
DK0983072T3 (da)	2004-12-06
DE69825887T2 (de)	2005-09-08
ES2223130T5 (es)	2009-01-16

Publication	Publication Date	Title
DK0983072T4 (da)	2008-09-22	Fruktanholdige sammensætninger til forebyggelse og behandling af coloncancer
LV10924A (lv)	1995-12-20	Sintetiskie katalitiskie brivo radikalu akceptori kurus izmanto ka antioksidantus slimibu profilaksei un arstesanai
NZ504026A (en)	2002-12-20	Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
DK0602702T3 (da)	1999-10-25	Anvendelse af tyloxapol som nanopartikelstabilisator og dispergeringsmiddel
BG106057A (en)	2002-04-30	Method of enhancing the efficacy of anti-tumour agents
KR900007424A (ko)	1990-06-01	세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
ES2136167T3 (es)	1999-11-16	Composiciones de idebenona para tratar la enfermedad de alzheimer.
PT1007055E (pt)	2004-06-30	Utilizacao de amifostina
KR950703353A (ko)	1995-09-20	인슐린-의존적 진성 당뇨병을 예방 또는 치료하기 위한 인터루킨-10의 용도(Use of IL-10 to prevent or treat insulin-dependent diabetes mellitus)
BR9809678A (pt)	2000-07-11	Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
AU5170499A (en)	2000-02-28	Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis
ATE334589T1 (de)	2006-08-15	Anti-arrhythmische zusammensetzungen und behandlungsverfahren
KR970703763A (ko)	1997-08-09	간 재생용 치료제(therapeutic agent for liver regeneration)
DE69021304D1 (de)	1995-09-07	Vorbeugendes und therapeutisches Mittel gegen Hepatitis.
NZ533309A (en)	2006-03-31	Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
WO1991015466A3 (en)	1991-11-28	Aminopolycarboxylic acid chelating agents
CA2158173A1 (en)	1994-09-29	Method of treating addictive behaviors
LV11593A (lv)	1996-12-20	Dimetikona pielietojums aizcietejumu arstesana
EP0519983A4 (en)	1993-03-10	Use of ketorolac for treatment of periodontal disease
NO960545D0 (no)	1996-02-12	Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
WO2001042205A3 (en)	2002-03-21	Treatment of inflammatory bowel disease with vitamin d compounds
DE59811643D1 (de)	2004-08-05	Haarbehandlungsmittel
IL98199A0 (en)	1992-06-21	Pharmaceutical compositions containing a derivative of substituted-l-valyl-l-prolinamide
IL98200A0 (en)	1992-06-21	Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
GR3029898T3 (en)	1999-07-30	Use of Etofibrate and pharmaceutical compositions containing etofibrate in the treatment of diabetic angio- and retinopathy.